Correlation Between Recursion Pharmaceuticals and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Champions Oncology, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Champions Oncology.
Diversification Opportunities for Recursion Pharmaceuticals and Champions Oncology
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Recursion and Champions is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Champions Oncology go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Champions Oncology
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 1.13 times less return on investment than Champions Oncology. In addition to that, Recursion Pharmaceuticals is 1.45 times more volatile than Champions Oncology. It trades about 0.13 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.21 per unit of volatility. If you would invest 391.00 in Champions Oncology on September 1, 2024 and sell it today you would earn a total of 61.00 from holding Champions Oncology or generate 15.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Champions Oncology
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Champions Oncology |
Recursion Pharmaceuticals and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Champions Oncology
The main advantage of trading using opposite Recursion Pharmaceuticals and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |